These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 2694236)
1. Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearance. Harrison NK; Glanville AR; Strickland B; Haslam PL; Corrin B; Addis BJ; Lawrence R; Millar AB; Black CM; Turner-Warwick M Respir Med; 1989 Sep; 83(5):403-14. PubMed ID: 2694236 [TBL] [Abstract][Full Text] [Related]
2. Fibrosing alveolitis in systemic sclerosis. Bronchoalveolar lavage findings in relation to computed tomographic appearance. Wells AU; Hansell DM; Rubens MB; Cullinan P; Haslam PL; Black CM; Du Bois RM Am J Respir Crit Care Med; 1994 Aug; 150(2):462-8. PubMed ID: 8049830 [TBL] [Abstract][Full Text] [Related]
3. Bronchoalveolar lavage in systemic sclerosis with lung involvement: role and correlations with functional, radiological and scintigraphic parameters. Volpinari S; La Corte R; Bighi S; Ravenna F; Prandini N; Lo Monaco A; Trotta F Rheumatol Int; 2011 Sep; 31(9):1183-8. PubMed ID: 20352228 [TBL] [Abstract][Full Text] [Related]
4. Clearance of inhaled 99mTc-DTPA predicts the clinical course of fibrosing alveolitis. Wells AU; Hansell DM; Harrison NK; Lawrence R; Black CM; du Bois RM Eur Respir J; 1993 Jun; 6(6):797-802. PubMed ID: 8339797 [TBL] [Abstract][Full Text] [Related]
5. Clearance of inhaled technetium-99m-DTPA as a clinical index of pulmonary vascular disease in systemic sclerosis. Kon OM; Daniil Z; Black CM; du Bois RM Eur Respir J; 1999 Jan; 13(1):133-6. PubMed ID: 10836337 [TBL] [Abstract][Full Text] [Related]
6. Evaluation and management of scleroderma lung disease using bronchoalveolar lavage. Silver RM; Miller KS; Kinsella MB; Smith EA; Schabel SI Am J Med; 1990 May; 88(5):470-6. PubMed ID: 2337105 [TBL] [Abstract][Full Text] [Related]
7. Bronchoalveolar lavage cellularity: lone cryptogenic fibrosing alveolitis compared with the fibrosing alveolitis of systemic sclerosis. Wells AU; Hansell DM; Haslam PL; Rubens MB; Cailes J; Black CM; du Bois RM Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1474-82. PubMed ID: 9603126 [TBL] [Abstract][Full Text] [Related]
8. Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity. Miller KS; Smith EA; Kinsella M; Schabel SI; Silver RM Am Rev Respir Dis; 1990 Feb; 141(2):301-6. PubMed ID: 2301848 [TBL] [Abstract][Full Text] [Related]
9. Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosis. De Santis M; Bosello S; La Torre G; Capuano A; Tolusso B; Pagliari G; Pistelli R; Danza FM; Zoli A; Ferraccioli G Respir Res; 2005 Aug; 6(1):96. PubMed ID: 16107215 [TBL] [Abstract][Full Text] [Related]
10. Pulmonary involvement in diffuse cutaneous systemic sclerosis: broncheoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis. Witt C; Borges AC; John M; Fietze I; Baumann G; Krause A Ann Rheum Dis; 1999 Oct; 58(10):635-40. PubMed ID: 10491363 [TBL] [Abstract][Full Text] [Related]
11. Clearance of technetium-99m-DTPA and HRCT findings in the evaluation of patients with Idiopathic Pulmonary Fibrosis. Antoniou KM; Malagari K; Tzanakis N; Perisinakis K; Symvoulakis EK; Karkavitsas N; Siafakas NM; Bouros D BMC Pulm Med; 2006 Feb; 6():4. PubMed ID: 16483363 [TBL] [Abstract][Full Text] [Related]
12. Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung. Behr J; Vogelmeier C; Beinert T; Meurer M; Krombach F; König G; Fruhmann G Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):400-6. PubMed ID: 8756813 [TBL] [Abstract][Full Text] [Related]
13. Transfer of 99mTc DTPA and bronchoalveolar lavage findings in patients with asymptomatic extrinsic allergic alveolitis. Schmekel B; Wollmer P; Venge P; Linden M; Blom-Bülow B Thorax; 1990 Jul; 45(7):525-9. PubMed ID: 2168589 [TBL] [Abstract][Full Text] [Related]
14. Early pulmonary involvement in systemic sclerosis assessed by technetium-99m-DTPA clearance rate. Fanti S; De Fabritiis A; Aloisi D; Dondi M; Marengo M; Compagnone G; Fallani F; Cavalli A; Monetti N J Nucl Med; 1994 Dec; 35(12):1933-6. PubMed ID: 7989973 [TBL] [Abstract][Full Text] [Related]
15. Fibroblast chemotactic response elicited by native bronchoalveolar lavage fluid from patients with fibrosing alveolitis. Behr J; Adelmann-Grill BC; Krombach F; Beinert T; Schwaiblmair M; Fruhmann G Thorax; 1993 Jul; 48(7):736-42. PubMed ID: 8153923 [TBL] [Abstract][Full Text] [Related]
16. Mast cells' contribution to the fibrosing alveolitis of the scleroderma lung. Chanez P; Lacoste JY; Guillot B; Giron J; Barnéon G; Enander I; Godard P; Michel FB; Bousquet J Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1497-502. PubMed ID: 8503561 [TBL] [Abstract][Full Text] [Related]